PL376564A1 - Nowe związki - Google Patents
Nowe związkiInfo
- Publication number
- PL376564A1 PL376564A1 PL376564A PL37656403A PL376564A1 PL 376564 A1 PL376564 A1 PL 376564A1 PL 376564 A PL376564 A PL 376564A PL 37656403 A PL37656403 A PL 37656403A PL 376564 A1 PL376564 A1 PL 376564A1
- Authority
- PL
- Poland
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0203070A SE0203070D0 (en) | 2002-10-16 | 2002-10-16 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL376564A1 true PL376564A1 (pl) | 2006-01-09 |
Family
ID=20289294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL376564A PL376564A1 (pl) | 2002-10-16 | 2003-10-15 | Nowe związki |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7407968B2 (pl) |
| EP (1) | EP1554254A1 (pl) |
| JP (1) | JP2006505568A (pl) |
| KR (1) | KR20050049551A (pl) |
| CN (1) | CN100349874C (pl) |
| AR (1) | AR041626A1 (pl) |
| AU (1) | AU2003269775B2 (pl) |
| BR (1) | BR0315320A (pl) |
| CA (1) | CA2501418A1 (pl) |
| IS (1) | IS7827A (pl) |
| MX (1) | MXPA05003901A (pl) |
| NO (1) | NO20052182L (pl) |
| NZ (1) | NZ539079A (pl) |
| PL (1) | PL376564A1 (pl) |
| RU (1) | RU2323211C2 (pl) |
| SE (1) | SE0203070D0 (pl) |
| TW (1) | TWI285638B (pl) |
| UA (1) | UA81919C2 (pl) |
| WO (1) | WO2004035548A1 (pl) |
| ZA (1) | ZA200502928B (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0101387D0 (sv) * | 2001-04-20 | 2001-04-20 | Astrazeneca Ab | Novel compounds |
| SE0203070D0 (en) | 2002-10-16 | 2002-10-16 | Astrazeneca Ab | Novel compounds |
| SE0301699D0 (sv) | 2003-06-10 | 2003-06-10 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| SE0301701D0 (sv) * | 2003-06-10 | 2003-06-10 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| SE0301698D0 (sv) * | 2003-06-10 | 2003-06-10 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| EP1809607B1 (en) * | 2004-11-02 | 2008-12-17 | Pfizer, Inc. | Sulfonyl benzimidazole derivatives |
| WO2007091950A1 (en) * | 2006-02-07 | 2007-08-16 | Astrazeneca Ab | Benzimidazoles and imidazopyridines useful in the treatment of diseases or disorders associated with cannabinoid receptor 2 (cb2) such as pain |
| PL2090570T3 (pl) | 2006-09-05 | 2012-03-30 | Kyowa Hakko Kirin Co Ltd | Pochodna imidazolu |
| JP5159630B2 (ja) * | 2006-09-13 | 2013-03-06 | 協和発酵キリン株式会社 | 縮環複素環誘導体 |
| BRPI0812504B8 (pt) | 2007-06-21 | 2021-05-25 | Cara Therapeutics Inc | composto para profilaxia ou tratamento de doença ou condição associada a receptor de canabinoides em sujeito mamífero |
| WO2009025785A2 (en) * | 2007-08-21 | 2009-02-26 | Merck & Co., Inc. | Cb2 receptor ligands for the treatment of pain |
| ES2679918T3 (es) | 2010-02-18 | 2018-08-31 | Vtv Therapeutics Llc | Derivados de imidazol condensados sustituidos, composiciones farmacéuticas y métodos de uso de los mismos |
| US8759535B2 (en) * | 2010-02-18 | 2014-06-24 | High Point Pharmaceuticals, Llc | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof |
| JP6162694B2 (ja) | 2011-07-18 | 2017-07-12 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | ベンズアミド類 |
| EP2872138A4 (en) | 2012-07-13 | 2016-04-20 | Cleveland Clinic Foundation | NEUROPROTECTIVE AGONISTS OF CB2 RECEPTORS |
| WO2016089648A1 (en) | 2014-12-01 | 2016-06-09 | Vtv Therapeutics Llc | Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof |
| CN111658644B (zh) * | 2020-03-31 | 2021-05-14 | 中山大学 | 一种小分子stat3抑制剂wz-2-033及其在制备治疗乳腺癌和胃癌药物中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2945044A (en) * | 1957-07-12 | 1960-07-12 | Ciba Pharm Prod Inc | Certain 1-(diethyl-aminoethyl), 5-amino, 2-benzyl or substituted benzyl, benzimidazoles |
| FR1481049A (fr) * | 1965-11-25 | 1967-05-19 | France Ministre Des Armees | Nouveaux dialkylaminoalkyl-1 p-alkoxyphényl alkyl-2 benzimidazoles 5-substitués |
| CA2036307C (en) * | 1990-03-08 | 2002-07-09 | Susan Jean Ward | 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method |
| FR2741621B1 (fr) * | 1995-11-23 | 1998-02-13 | Sanofi Sa | Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant |
| FR2789079B3 (fr) * | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant |
| AUPR118000A0 (en) * | 2000-11-02 | 2000-11-23 | Amrad Operations Pty. Limited | Therapeutic molecules and methods |
| CA2436133A1 (en) | 2001-01-29 | 2002-08-08 | University Of Connecticut | Receptor selective cannabimimetic aminoalkylindoles |
| SE0101387D0 (sv) * | 2001-04-20 | 2001-04-20 | Astrazeneca Ab | Novel compounds |
| AU2002347022A1 (en) * | 2001-12-20 | 2003-07-09 | Novo Nordisk A/S | Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten |
| SE0203070D0 (en) | 2002-10-16 | 2002-10-16 | Astrazeneca Ab | Novel compounds |
-
2002
- 2002-10-16 SE SE0203070A patent/SE0203070D0/xx unknown
-
2003
- 2003-10-09 TW TW092128115A patent/TWI285638B/zh not_active IP Right Cessation
- 2003-10-15 US US10/530,499 patent/US7407968B2/en not_active Expired - Fee Related
- 2003-10-15 UA UAA200502658A patent/UA81919C2/uk unknown
- 2003-10-15 RU RU2005109156/04A patent/RU2323211C2/ru not_active IP Right Cessation
- 2003-10-15 AR ARP030103753A patent/AR041626A1/es unknown
- 2003-10-15 AU AU2003269775A patent/AU2003269775B2/en not_active Ceased
- 2003-10-15 CA CA002501418A patent/CA2501418A1/en not_active Abandoned
- 2003-10-15 PL PL376564A patent/PL376564A1/pl not_active Application Discontinuation
- 2003-10-15 BR BR0315320-7A patent/BR0315320A/pt not_active IP Right Cessation
- 2003-10-15 JP JP2004545139A patent/JP2006505568A/ja active Pending
- 2003-10-15 NZ NZ539079A patent/NZ539079A/en unknown
- 2003-10-15 MX MXPA05003901A patent/MXPA05003901A/es not_active Application Discontinuation
- 2003-10-15 CN CNB2003801059214A patent/CN100349874C/zh not_active Expired - Fee Related
- 2003-10-15 WO PCT/SE2003/001604 patent/WO2004035548A1/en not_active Ceased
- 2003-10-15 KR KR1020057006538A patent/KR20050049551A/ko not_active Withdrawn
- 2003-10-15 EP EP03751705A patent/EP1554254A1/en not_active Withdrawn
-
2005
- 2005-04-11 ZA ZA200502928A patent/ZA200502928B/en unknown
- 2005-04-27 IS IS7827A patent/IS7827A/is unknown
- 2005-05-03 NO NO20052182A patent/NO20052182L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1726194A (zh) | 2006-01-25 |
| IS7827A (is) | 2005-04-27 |
| WO2004035548A1 (en) | 2004-04-29 |
| RU2323211C2 (ru) | 2008-04-27 |
| SE0203070D0 (en) | 2002-10-16 |
| CN100349874C (zh) | 2007-11-21 |
| TWI285638B (en) | 2007-08-21 |
| NO20052182L (no) | 2005-05-03 |
| EP1554254A1 (en) | 2005-07-20 |
| US20070105893A1 (en) | 2007-05-10 |
| ZA200502928B (en) | 2006-02-22 |
| CA2501418A1 (en) | 2004-04-29 |
| US7407968B2 (en) | 2008-08-05 |
| KR20050049551A (ko) | 2005-05-25 |
| UA81919C2 (uk) | 2008-02-25 |
| BR0315320A (pt) | 2005-08-16 |
| AR041626A1 (es) | 2005-05-26 |
| JP2006505568A (ja) | 2006-02-16 |
| NZ539079A (en) | 2007-11-30 |
| RU2005109156A (ru) | 2006-01-20 |
| TW200410944A (en) | 2004-07-01 |
| MXPA05003901A (es) | 2005-06-22 |
| AU2003269775B2 (en) | 2007-05-03 |
| AU2003269775A1 (en) | 2004-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0202216D0 (en) | Novel compounds | |
| GB0205256D0 (en) | Novel compounds | |
| GB0202679D0 (en) | Novel compounds | |
| GB0206723D0 (en) | Novel compounds | |
| GB0207249D0 (en) | Novel compounds | |
| GB0207246D0 (en) | Novel compounds | |
| GB0203299D0 (en) | Novel compounds | |
| GB0200025D0 (en) | Novel compounds | |
| GB0204252D0 (en) | Novel compounds | |
| GB0202442D0 (en) | Novel compounds | |
| GB0202217D0 (en) | Novel compounds | |
| GB0202140D0 (en) | Novel compounds | |
| GB0205649D0 (en) | Novel compounds | |
| GB0201357D0 (en) | Novel compounds | |
| GB0206201D0 (en) | Novel compounds | |
| GB0207275D0 (en) | Novel compounds | |
| GB0203901D0 (en) | Novel compounds | |
| GB0207281D0 (en) | Novel compounds | |
| GB0200108D0 (en) | Novel compounds | |
| GB0207283D0 (en) | Novel compounds | |
| GB0206716D0 (en) | Novel compounds | |
| GB0203680D0 (en) | Novel compounds | |
| GB0206714D0 (en) | Novel compounds | |
| GB0200787D0 (en) | Novel compounds | |
| GB0200109D0 (en) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |